A Randomized Controlled Trial to Explore the Efficacy of Stellate Ganglion Block in Obstructive Sleep Apnea
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Obstructive Sleep Apnea
- Sponsor
- Zeng Changhao
- Enrollment
- 80
- Locations
- 1
- Primary Endpoint
- Epworth Sleepiness Scale
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The goal of this clinical trial is to test the efficacy of stellate ganglion block in Obstructive Sleep Apnea. The main question it aims to answer are:
• Can stellate ganglion block improve Obstructive Sleep Apnea? Patients were randomly divided into two groups, all provided with routine therapy. Based on this, the experimental group was given stellate ganglion block. The video fluoroscopic swallowing study was done to test the swallowing function before and after the study.
Detailed Description
Obstructive Sleep Apnea is of increasingly high prevalence. The goal of this clinical trial is to test the efficacy of stellate ganglion block in Obstructive Sleep Apnea. The main question it aims to answer are: • Can stellate ganglion block improve Obstructive Sleep Apnea? Patients were randomly divided into two groups, all provided with routine therapy. Based on this, the experimental group was given stellate ganglion block. The video fluoroscopic swallowing study was done to test the swallowing function before and after the study.
Investigators
Zeng Changhao
Research Director
People's Hospital of Zhengzhou University
Eligibility Criteria
Inclusion Criteria
- •Patients aged over 18 years diagnosed with OSA by polysomnography
- •Patients with moderate to severe OSA (AHI \> 15 events per hour)
- •Patients who have undergone continuous positive airway pressure (CPAP) treatment for at least 3 months but have not achieved satisfactory therapeutic effects
- •Patients who voluntarily agree to receive stellate ganglion block (SGB) treatment and sign the informed consent form
Exclusion Criteria
- •Patients with a history of allergy or contraindications to local anesthetics or corticosteroids
- •Patients with severe cardiovascular, cerebrovascular, respiratory, hepatic, or renal diseases
- •Patients with a history of neck surgery or cervical spine disease
- •Patients with psychiatric disorders or other medical conditions that may affect the safety or effectiveness of SGB treatment
- •Pregnant or lactating women
- •Patients who have participated in other clinical trials within the past 3 months
Outcomes
Primary Outcomes
Epworth Sleepiness Scale
Time Frame: day 1 and day 20
This scale measures daytime sleepiness. By scoring the level of sleepiness in different situations, it can help evaluate whether a patient has OSA or other sleep disorders.Scores range from 0-24. Higher scores indicate more severe daytime sleepiness.
Secondary Outcomes
- Apnea-Hypopnea Index(day 1 and day 20)